As concerns mount over rising health care costs in the U.S., value frameworks have attempted to cushion the blow by offering society, payers and providers the tools to better analyze the value of brand-new therapies.
However, do these frameworks take innovation into account?
A Health Affairs Blog post published this week delves into this issue.
“At a societal level, support for continued progress is well recognized,” the authors write. “Our willingness to pay for today’s treatments reflects, to some degree, our desire to see the introduction of tomorrow’s treatments as well.”